Incyte Corporation (Nasdaq:INCY) announced today it will present at the following investor conferences:
- Baird 2009 Health Care Conference on Wednesday, September 9, 2009 at 10:00 a.m. (ET) in New York City;
- 2009 Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 15, 2009 at 11:30 a.m. (ET) in New York City; and
- UBS 2009 Global Life Sciences Conference on Monday, September 21, 2009 at 12:00 p.m. (ET) in New York City.
The presentations will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentations will be available. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology, inflammation and diabetes. Incyte’s most advanced compound, INCB18424, is in Phase III development for myelofibrosis. For additional information on Incyte, visit the Company''s web site at www.incyte.com.
Contacts:
Incyte Corporation
Pamela M. Murphy
Vice
President, Investor Relations/Corporate Communications
302-498-6944
